PROF Stock Price, Chart, Stats & News

Profound Medical Corp.
Save
207.88M
Market cap
–
Current P/E
–
Forward P/E
PROF chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | 70.77% |
Operating margin | -256.27% |
Pretax margin | 262.88% |
Net margin | -263.90% |
Effective tax rate | 0.59% |
ROA | -22.02% |
ROE | -79.71% |
D/E | 0.07x |
Interest coverage ratio | – |
PROF valuation
P/E | – |
P/S | 11.64x |
P/B | 2.09x |
P/CF | -4.95x |
P/FCF | -4.88x |
P/OCF | -4.95x |
PEG | 0.36x |
EV multiple | -6.19x |
About
Profound Medical Corp., through its subsidiaries, is a commercial-stage medical technology firm specializing in the development of magnetic resonance (MR)-guided ablation solutions. These innovative procedures are designed to treat conditions such as prostate disease and uterine fibroids, as well as providing palliative pain relief. The company markets its solutions across Canada, Germany, the United States, and Finland.
Similar securities
Based on sector and market capitalization
Report issue











